tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Fate Therapeutics Inc

FATE
Add to Watchlist
2.260USD
-0.170-7.00%
Market hours （ET）Quotes delayed by 15 min
262.78MMarket Cap
LossP/E TTM

Fate Therapeutics Inc

2.260
-0.170-7.00%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

FATE Financials

See Fate Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Fate Therapeutics Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.26/-0.28
Revenue / Forecast
1.30M/1.14M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
6.65M
-51.24%
EPS(YoY)
-1.15
29.96%
Analyst Rating
BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
18.18%-0.26
38.67%-0.27
33.06%-0.27
12.13%-0.29
33.06%-0.32
1.07%-0.44
11.66%-0.40
38.98%-0.33
-146.57%-0.47
22.82%-0.45
---0.46
---0.54
---0.19
---0.58
---2.33
----
----
----
----
----
Revenue
-20.26%1.30M
-26.40%1.37M
-43.36%1.74M
-71.84%1.91M
-15.38%1.63M
10.98%1.86M
58.13%3.07M
625.83%6.77M
-96.74%1.93M
-96.22%1.68M
-87.02%1.94M
-94.97%933.00K
220.30%58.98M
159.86%44.36M
5.31%14.98M
38.30%18.55M
65.27%18.41M
7.38%17.07M
88.21%14.22M
145.42%13.41M
Net Profit
17.03%-31.21M
37.92%-32.37M
32.36%-32.25M
11.34%-34.07M
21.63%-37.62M
-18.20%-52.15M
-5.55%-47.68M
27.16%-38.43M
-154.25%-48.00M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
17.86%-56.36M
-92.95%-83.56M
-38.04%-76.11M
-45.69%-65.69M
-29.20%-68.62M
26.20%-43.31M
-96.40%-55.13M
Net Margin
-4.04%-2402.85%
15.66%-2364.79%
-19.43%-1852.38%
-214.85%-1786.58%
7.39%-2309.45%
-6.51%-2803.92%
33.25%-1551.01%
89.96%-567.44%
-7689.80%-2493.71%
-1971.76%-2632.58%
---2323.56%
---5654.34%
---32.01%
---127.07%
---433.85%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
--3.71%
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
-20.26%1.30M
-26.40%1.37M
-43.36%1.74M
-71.84%1.91M
-15.38%1.63M
10.98%1.86M
58.13%3.07M
625.83%6.77M
-96.74%1.93M
-96.22%1.68M
-87.02%1.94M
-94.97%933.00K
220.30%58.98M
159.86%44.36M
5.31%14.98M
38.30%18.55M
65.27%18.41M
7.38%17.07M
88.21%14.22M
145.42%13.41M
Operating profit
20.06%-33.00M
26.14%-34.72M
33.68%-34.73M
18.00%-36.97M
19.17%-41.28M
2.21%-47.01M
-2.14%-52.38M
27.94%-45.08M
-78.61%-51.07M
25.37%-48.08M
40.64%-51.28M
24.72%-62.56M
61.60%-28.59M
7.15%-64.42M
-58.16%-86.39M
-77.66%-83.11M
-61.15%-74.47M
-107.74%-69.38M
-73.48%-54.62M
-62.95%-46.78M
Net Profit
17.03%-31.21M
37.92%-32.37M
32.36%-32.25M
11.34%-34.07M
21.63%-37.62M
-18.20%-52.15M
-5.55%-47.68M
27.16%-38.43M
-154.25%-48.00M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
17.86%-56.36M
-92.95%-83.56M
-38.04%-76.11M
-45.69%-65.69M
-29.20%-68.62M
26.20%-43.31M
-96.40%-55.13M
Balance Sheet
Current assets
-27.67%179.53M
-28.50%208.70M
-28.70%221.25M
-27.86%230.40M
-37.06%248.22M
-11.95%291.91M
-14.80%310.29M
-18.56%319.39M
-9.94%394.38M
-33.97%331.54M
-31.97%364.17M
-34.54%392.18M
-26.91%437.89M
-20.74%502.07M
-22.83%535.33M
-16.00%599.16M
-25.52%599.08M
28.14%633.41M
39.64%693.71M
32.03%713.27M
Total current liabilities
8.98%30.69M
-6.36%36.07M
-24.88%28.11M
-17.59%28.67M
-37.93%28.16M
-1.46%38.52M
-9.46%37.42M
-22.15%34.79M
-6.75%45.37M
-65.72%39.09M
-60.23%41.33M
-51.17%44.69M
-37.56%48.65M
40.31%114.05M
13.12%103.94M
-13.34%91.52M
-17.62%77.91M
-5.00%81.28M
69.54%91.88M
133.00%105.60M
Total assets
-28.53%284.92M
-27.63%318.94M
-30.57%343.67M
-29.72%371.63M
-30.04%398.67M
-12.94%440.69M
-8.98%494.97M
-9.57%528.82M
-9.59%569.89M
-28.25%506.22M
-27.43%543.79M
-27.54%584.76M
-26.57%630.34M
-23.43%705.56M
-23.89%749.35M
-20.54%807.06M
-17.93%858.39M
48.04%921.46M
57.17%984.57M
55.40%1.02B
Total liabilities
-4.58%105.21M
-8.38%111.75M
-17.37%109.61M
-16.36%110.27M
-23.31%110.26M
-11.49%121.97M
-5.93%132.64M
-10.32%131.84M
-5.94%143.78M
-37.82%137.80M
-39.05%141.01M
-35.12%147.00M
-32.06%152.86M
-8.65%221.62M
-9.00%231.35M
-14.04%226.58M
-12.07%224.99M
1.93%242.62M
25.81%254.24M
46.86%263.60M
Total equity
-37.69%179.71M
-35.00%207.18M
-35.40%234.07M
-34.16%261.36M
-32.32%288.41M
-13.49%318.73M
-10.04%362.33M
-9.31%396.98M
-10.76%426.12M
-23.87%368.42M
-22.24%402.78M
-24.59%437.75M
-24.62%477.47M
-28.71%483.94M
-29.07%518.00M
-22.82%580.48M
-19.83%633.39M
76.58%678.84M
72.10%730.33M
58.63%752.07M
Cash Flow Statement
Net operating income
8.83%-30.82M
16.13%-23.31M
17.15%-24.37M
23.89%-24.59M
-1.38%-33.81M
24.12%-27.80M
23.13%-29.42M
-13.38%-32.31M
-15.56%-33.35M
51.40%-36.64M
30.47%-38.27M
46.40%-28.49M
55.33%-28.86M
-7.25%-75.39M
-64.93%-55.05M
-65.57%-53.16M
-138.46%-64.61M
-240.17%-70.29M
-8.60%-33.38M
-182.66%-32.11M
Net investment
-44.73%23.59M
21.10%27.63M
-16.45%21.27M
136.71%19.59M
146.47%42.67M
-49.69%22.82M
2.64%25.46M
-260.92%-53.37M
85.37%17.31M
-14.61%45.35M
-69.14%24.80M
-17.67%33.17M
232.93%9.34M
-25.49%53.11M
3.10%80.38M
3036.37%40.29M
98.51%-7.03M
142.93%71.28M
243.99%77.96M
-103.88%-1.37M
Net financing
----
-46.01%1.69M
--2.48M
4.00%1.32M
-100.00%0.00
1838.89%3.13M
--0.00
2096.55%1.27M
46029.47%95.49M
-111.87%-180.00K
-100.00%0.00
-98.30%58.00K
-92.60%207.00K
-55.62%1.52M
-81.28%1.49M
-8.42%3.41M
-99.36%2.80M
-30.39%3.42M
753.98%7.94M
-98.65%3.72M

FAQs

What is the total revenue of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its total revenue reached 6.65M, with a year-on-year change of 13.63M.

What are the current assets of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its current assets were 208.70M, with a year-on-year change of -28.50.

What are the total assets of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its total assets of Fate Therapeutics Inc were 318.94M, with a year-on-year change of -27.63.

What are the total liabilities of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its total liabilities of Fate Therapeutics Inc were 111.75M, with a year-on-year change of -8.38.

What is the total equity of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its total equity of Fate Therapeutics Inc was 207.18M, with a year-on-year change of -35.00.

What is the net operating income of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its net operating income of Fate Therapeutics Inc was -147.70M, with a year-on-year change of 24.46.

What is the net investment of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its net investment of Fate Therapeutics Inc was 111.17M, with a year-on-year change of 809.85.

What is the net financing of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its net financing of Fate Therapeutics Inc was 5.49M, with a year-on-year change of -94.50.

What is the Earnings Per Share (EPS) of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.15, with a year-on-year change of 29.96.

What is the net income of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its net income was -136.31M, with a year-on-year change of 26.82.

What is the net margin of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its net profit margin was -2051.08, with a year-on-year change of -50.10.

What is the Return on Equity (ROE) of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -51.84, with a year-on-year change of 4.38.

What is the Return on Assets (ROA) of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.89, with a year-on-year change of 8.77.

What is the operating profit of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its operating profit was -147.70M, with a year-on-year change of 24.46.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy